crRNA, Cas proteins are assembled with crRNA, with the 5′ end recognized by Cas8 and the 3′ stem-loop held by Cas6, which is kinked by Cas7 thumb motifs in a periodic "5+1" pattern (Supplementary information, Fig. S3c ).
Our Cascade crRNA -TniQ-dsDNA ternary complex contains a G-G/C-C PAM (protospacer adjacent motif) sequence ( Fig. 1b) , which is required for binding of the target sequence, allowing CRISPR-Cas systems to discriminate between self and non-self. 10 The target sequence contains 12-base pair (bp) of PAM-proximal duplex DNA and 51-bp of PAM-distal duplex DNA ( Fig. 1c ; Supplementary information, Fig. S4 ). We could observe only 5-bp of PAM-proximal duplex DNA with 2-nt overhang at the 3′ end of the non-target strand (NTS), and a traceable 32-nt target DNA strand complementary and paired to 32-nt spacer RNA, but no clear density for the PAM-distal duplex segment, which is adjacent to bound TniQ. The traceable parts of the crRNA-dsDNA are colored, while non-traceable parts are shown in grey ( Fig. 1c ; Supplementary information, Fig. S4 ). The G-G/C-C PAM is specifically recognized by Ser127 and Asn246 in Cas8 ( Fig. 1d ). Arg243 forms a wedge and stacks with PAM G (-1), facilitating the formation of crRNA-target DNA heteroduplex and displacing the NTS, thus leading to the onset of R-loop formation.
It has been proposed that the transposition protein TniQ serves as an important connection between sequence-specific DNA targeting by the Cascade crRNA complex and DNA transposition by the accompanying transposase subunits TnsA, TnsB, and TnsC. 5 In line with this concept, we observe that TniQ forms a head-to-tail dimer whose individual monomers simultaneously bind to Cas6 and Cas7.1 of the Cascade crRNA complex (Fig. 1b, c) , with clear density observed at the interface between TniQ and both Cas6 and Cas7.1. One TniQ interacts with Cas6 via a main chain polar interaction between Val268 and Asn16, whereas the other TniQ interacts with Cas7.1 by multiple polar interactions between side chains over a larger interface ( Fig. 1e , inset). We also determined the crystal structure of apo-TniQ at 2.1 Å resolution, demonstrating that TniQ forms a head-to-tail dimer with a dimeric interface of 1931 Å 2 (Supplementary information, Fig. S5a ). The dimer result was confirmed by SEC-MALS in solution (Supplementary information, Fig. S5b ). Superposition of the TniQ dimer in the cryo-EM structure of ternary Cascade crRNA -TniQ-dsDNA complex (in color) with the crystal structure of the apo-form (in grey) reveals minimal conformational changes with an RMSD of 1.19 Å; the loop interacting with Cas6 becomes ordered and the helix interacting with Cas7.1 undergoes slight movement (circled in green, Supplementary information, Fig. S5c) .
Notably, the binary and DNA-bound ternary Cascade crRNA -TniQ complexes superpose with an RMSD of 2.33 Å. Minimal conformational changes are observed on ternary complex formation in the presence of bound target DNA, reflecting slight opening of the entire complex ( Fig. 1f) and crRNA (Fig. 1g) , especially within the TniQ-bound end.
Our studies, and a parallel contribution 11 provide insights into DNA targeting by the Cascade crRNA -TniQ complex, which represents an essential initial step in crRNA-guided DNA integration. The studies also provide structural insights into the potential use of RNAguided Tn7-like transposons for genome editing. Further studies are required to investigate how the Cascade crRNA -TniQ complex recruits other transposon-associated proteins (TnsA, TnsB, and TnsC) to facilitate DNA transposition.
The atomic coordinates and EM maps have been deposited into the Protein Data Bank with the accession numbers 6V9P, 6V9Q, and 6VBW, and the EM Data Bank with the accession numbers EMD-21126 and EMD-21146. (P30 GM124165). The Pilatus 6M detector on 24-ID-C beamline is funded by a NIH-ORIP HEI grant (S10 RR029205). This research was, in part, supported by the National Cancer Institute's National Cryo-EM Facility at the Frederick National Laboratory for Cancer Research under contract HSSN261200800001E. This research was supported by funds from the Geoffrey Beene Cancer Research Center and NIH GM129430 to D.J.P., and by Memorial Sloan-Kettering Cancer Center Core Grant (P30CA008748).
